Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy
Clinical trial NCT04386304 · COMPLETED
Trial details
- NCT number
- NCT04386304
- Sponsor
- Epirium Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2022-03-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.